A U.S. Senate investigation found that Gilead Sciences puts its profits ahead of patients who need life-saving hepatitis C drugs.
12 Aug '24 10:39AM
09 Aug '24 16:35PM
09 Aug '24 16:25PM
09 Aug '24 15:37PM